SLXNW

Silexion Therapeutics Ltd. SLXNW

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SLXNW REVB VRPX AKTX CDT DRMA PPBT XAGE PBM BDRX
6M -23.37 % -84.89 % -94.76 % -25.46 % -95.53 % 508.45 % -74.41 % -87.84 % 8.92 % -44.45 %
YTD 54.18 % -95.69 % -99.88 % -32.24 % -99.54 % 210.79 % -86.01 % -97.21 % -75.69 % -80.17 %
1Y -29.64 % -96.68 % -99.92 % -67.46 % -99.70 % 224.81 % -84.34 % -96.93 % -93.87 % -90.35 %
3Y -77.24 % -99.99 % -100.00 % -91.63 % -100.00 % -97.41 % -98.35 % -99.80 % -99.91 % -99.99 %
5Y -77.24 % -100.00 % -100.00 % -97.67 % -100.00 % -99.65 % -99.26 % -99.80 % -99.91 % -100.00 %
10Y -77.24 % -100.00 % -100.00 % -99.78 % -100.00 % -99.65 % -99.90 % -99.80 % -99.91 % -100.00 %
From the beginning -77.24 % -100.00 % -100.00 % -99.74 % -100.00 % -99.65 % -99.90 % -99.80 % -99.91 % -100.00 %

Dividend